Statement from FDA on continuing efforts to maintain its strong oversight of generic drugs
date:Feb 25, 2019
aining the quality of these medicines while helping patients and payers realize more of the benefits from high quality, low cost generics. We continue to take new steps to address the challenges posed by a global supply chain and encourage the adoption of new advanced manufacturing methods. These actions are key parts of our commitment to ensure high-quality manufacturing, and to make sure Americans have confidence in the quality of products in their medicine cabinets regardless of where they w
34/35 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/16 12:16